Terms: = Leukemia AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Treatment
22 results:
1. Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.
Gill H; Raghupathy R; Lee CYY; Yung Y; Chu HT; Ni MY; Xiao X; Flores FP; Yim R; Lee P; Chin L; Li VWK; Au L; Au WY; Ma ESK; Mohan D; Kumana CR; Kwong YL
BMC Cancer; 2023 Feb; 23(1):141. PubMed ID: 36765318
[TBL] [Abstract] [Full Text] [Related]
2. Enhancing Administrative Claims Data: Feasibility, Validation and Application of Linking Medicare Claims Data and National Marrow Donor Program Search Data.
Preussler JM; Meyer CL; Sees Coles JA; Yoo D; Mau LW; Garrett ND; Auletta JJ
JCO Clin Cancer Inform; 2022 Oct; 6():e2200069. PubMed ID: 36228178
[TBL] [Abstract] [Full Text] [Related]
3. IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load.
Hussmann D; Starnawska A; Kristensen L; Daugaard I; Thomsen A; Kjeldsen TE; Hansen CS; Bybjerg-Grauholm J; Johansen KD; Ludvigsen M; Kristensen T; Larsen TS; Møller MB; Nyvold CG; Hansen LL; Wojdacz TK
Haematologica; 2022 Apr; 107(4):877-886. PubMed ID: 34092057
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemia.
Hazar V; Tezcan Karasu G; Öztürk G; Küpesiz A; Aksoylar S; Özbek N; Uygun V; İleri T; Okur FV; Koçak Ü; Kılıç SÇ; Akçay A; Güler E; Kansoy S; Karakükcü M; Bayram İ; Aksu T; Yeşilipek A; Karagün BŞ; Yılmaz Ş; Ertem M; Uçkan D; Fışgın T; Gürsel O; Yaman Y; Bozkurt C; Gökçe M;
Pediatr Transplant; 2021 Aug; 25(5):e13942. PubMed ID: 33320995
[TBL] [Abstract] [Full Text] [Related]
5. CD34+ selected peripheral blood Stem Cell Boost (SCB) for Poor Graft Function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: Results of a retrospective multicenter study.
Berger M; Faraci M; Saglio F; Giardino S; Ernestina Vassallo E; Prete A; Fagioli F
Pediatr Transplant; 2021 Aug; 25(5):e13909. PubMed ID: 33141997
[TBL] [Abstract] [Full Text] [Related]
6. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
[TBL] [Abstract] [Full Text] [Related]
7. Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia.
Hartmann L; Nadarajah N; Meggendorfer M; Höllein A; Vetro C; Kern W; Haferlach T; Haferlach C; Stengel A
Leukemia; 2020 Mar; 34(3):811-820. PubMed ID: 31719678
[TBL] [Abstract] [Full Text] [Related]
8. JTE-607, a multiple cytokine production inhibitor, targets CPSF3 and inhibits pre-mRNA processing.
Kakegawa J; Sakane N; Suzuki K; Yoshida T
Biochem Biophys Res Commun; 2019 Oct; 518(1):32-37. PubMed ID: 31399191
[TBL] [Abstract] [Full Text] [Related]
9. Allogeneic Stem Cell Transplantation for Acute Lymphoblastic leukemia in Adolescents and Young Adults.
Hangai M; Urayama KY; Tanaka J; Kato K; Nishiwaki S; Koh K; Noguchi M; Kato K; Yoshida N; Sato M; Goto H; Yuza Y; Hashii Y; Atsuta Y; Mizuta S; Kato M
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1597-1602. PubMed ID: 31002992
[TBL] [Abstract] [Full Text] [Related]
10. Adolescence and Socioeconomic Factors: Key Factors in the Long-Term Impact of leukemia on Scholastic Performance-A LEA Study.
Bonneau J; Berbis J; Michel G; Vercasson C; Bertrand Y; Ansoborlo S; Dalle JH; Baruchel A; Tabone MD; Paillard C; Contet A; Poirée M; Sirvent N; Thouvenin S; Kanold J; Freycon C; Saultier P; Auquier P; Gandemer V
J Pediatr; 2019 Feb; 205():168-175.e2. PubMed ID: 30442413
[TBL] [Abstract] [Full Text] [Related]
11. Clinical and molecular characteristics of
Ohki K; Kiyokawa N; Saito Y; Hirabayashi S; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fukushima K; Hasegawa D; Fukushima H; Imai M; Kajiwara R; Koike T; Komori I; Matsui A; Mori M; Moriwaki K; Noguchi Y; Park MJ; Ueda T; Yamamoto S; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Takahashi H; Fukushima T; Hayashi Y; Koh K; Manabe A; Ohara A;
Haematologica; 2019 Jan; 104(1):128-137. PubMed ID: 30171027
[TBL] [Abstract] [Full Text] [Related]
12. Characterisation of clonal Philadelphia-negative cytogenetic abnormalities in a large cohort of chronic myeloid leukaemia.
Chen X; Zheng J; Liang K; He Y; Du W; Li J; Liu W; Hu Y; Huang S; Yao J
Intern Med J; 2018 Apr; 48(4):439-444. PubMed ID: 28636094
[TBL] [Abstract] [Full Text] [Related]
13. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
Gu Z; Churchman M; Roberts K; Li Y; Liu Y; Harvey RC; McCastlain K; Reshmi SC; Payne-Turner D; Iacobucci I; Shao Y; Chen IM; Valentine M; Pei D; Mungall KL; Mungall AJ; Ma Y; Moore R; Marra M; Stonerock E; Gastier-Foster JM; Devidas M; Dai Y; Wood B; Borowitz M; Larsen EE; Maloney K; Mattano LA; Angiolillo A; Salzer WL; Burke MJ; Gianni F; Spinelli O; Radich JP; Minden MD; Moorman AV; Patel B; Fielding AK; Rowe JM; Luger SM; Bhatia R; Aldoss I; Forman SJ; Kohlschmidt J; Mrózek K; Marcucci G; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Paietta E; Willman CL; Loh ML; Hunger SP; Mullighan CG
Nat Commun; 2016 Nov; 7():13331. PubMed ID: 27824051
[TBL] [Abstract] [Full Text] [Related]
14. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract] [Full Text] [Related]
15. Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Warren RS; Atreya CE; Niedzwiecki D; Weinberg VK; Donner DB; Mayer RJ; Goldberg RM; Compton CC; Zuraek MB; Ye C; Saltz LB; Bertagnolli MM
Clin Cancer Res; 2013 Oct; 19(20):5777-87. PubMed ID: 23983256
[TBL] [Abstract] [Full Text] [Related]
16. Identification of novel FLT3 kinase inhibitors.
Pauwels D; Klaassen H; Lahortiga I; Kilonda A; Jacobs K; Sweron B; Corbau R; Chaltin P; Marchand A; Cools J
Eur J Med Chem; 2013 May; 63():713-21. PubMed ID: 23567961
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenic mechanisms of Evi-1 protein.
Hirai H; Izutsu K; Kurokawa M; Mitani K
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S35-40. PubMed ID: 11587364
[TBL] [Abstract] [Full Text] [Related]
18. Retinal abnormalities in newly diagnosed adult acute myeloid leukemia.
Specchia G; Albano F; Guerriero S; Buquicchio C; Pomes L; Pastore D; Carluccio P; Delle Noci N; Liso V
Acta Haematol; 2001; 105(4):197-203. PubMed ID: 11528093
[TBL] [Abstract] [Full Text] [Related]
19. High incidence of meningioma among Hiroshima atomic bomb survivors.
Shintani T; Hayakawa N; Hoshi M; Sumida M; Kurisu K; Oki S; Kodama Y; Kajikawa H; Inai K; Kamada N
J Radiat Res; 1999 Mar; 40(1):49-57. PubMed ID: 10408177
[TBL] [Abstract] [Full Text] [Related]
20. Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML.
de Nully Brown P; Hoffmann T; Hansen OP; Boesen AM; Grønbaek K; Hippe E; Jensen MK; Thorling K; Storm HH; Pedersen-Bjergaard J
Leukemia; 1997 Jan; 11(1):37-41. PubMed ID: 9001416
[TBL] [Abstract] [Full Text] [Related]
[Next]
